What is 4Front Ventures Corp. (FFNTF) stock price today?

4Front Ventures Corp. (FFNTF) is currently trading at $0.00.

What is FFNTF P/E ratio?

4Front Ventures Corp.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is FFNTF return on equity (ROE)?

4Front Ventures Corp.'s return on equity (ROE) is 176.92%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is 4Front Ventures Corp.'s market cap?

4Front Ventures Corp. has a market capitalization of $1246.

OTC · Drug Manufacturers - Specialty & Generic

4Front Ventures Corp. (FFNTF) Stock

$0.00 OTC: FFNTF Healthcare

4Front Ventures Corp. is an American company specializing in the management and operation of licensed cannabis facilities across various U.S.

Valuation

Metric	Value
Price	$0.00
Market Cap	$1246
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-0.11
52-Week High	$0.07
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	176.92%
ROA	-5.05%
ROCE	-13.03%
Gross Margin	35.57%
Operating Margin	-38.41%
Net Margin	-48.15%
Debt/Equity	-4.04
Current Ratio	0.34

Annual Financials (USD)

Metric	2019	2020	2021	2022	2023
Revenue	$19.0M	$58.0M	$105.0M	$108.0M	$97.0M
Operating Profit	$-180.0M	$-33.0M	$-14.0M	$-15.0M	$-21.0M
Net Profit	$-181.0M	$-47.0M	$-38.0M	$-47.0M	$-92.0M
EPS	$-0.43	$-0.09	$-0.06	$-0.07	$-0.14
Op Margin	-944.9%	-56.6%	-13.3%	-13.9%	-21.4%

Balance Sheet (USD)

Metric	2019	2020	2021	2022	2023
Total Assets	$204.0M	$205.0M	$256.0M	$345.0M	$264.0M
Total Liabilities	$128.0M	$163.0M	$215.0M	$316.0M	$315.0M
Cash	$6.0M	$19.0M	$23.0M	$15.0M	$3.0M
Borrowings	$110.0M	$120.0M	$168.0M	$224.0M	$210.0M

Cash Flow (USD)

Metric	2019	2020	2021	2022	2023
Operating Cash Flow	$-25.0M	$-14.0M	$6.0M	$9.0M	$-2.0M
Investing Cash Flow	$-43.0M	$25.0M	$-27.0M	$-29.0M	$-7.0M
Financing Cash Flow	$-5.0M	$4.0M	$-1.0M	$0	$-1.0M
Net Cash Flow	$4.0M	$11.0M	$4.0M	$-7.0M	$-11.0M
Free Cash Flow	$-48.0M	$-28.0M	$-8.0M	$6.0M	$-5.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-13.69
FCF Yield	-417094.70%
Quick Ratio	0.16
Interest Coverage	-1.51
Return 1Y	-99.05%
Return 3Y	-99.99%
Return 5Y	—

Ownership

Insiders Held51.06%

Institutions Held6.72%

Institutions Float Held13.73%

Institutional Holder	Shares	Report Date
Connectus Wealth, LLC	37,900	2024-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
CWWBFPlant-Based Investment Corp.	$0.00	—	0.00	$275	0.00%
DRWNQuantum Medical Transport, Inc.	$0.00	—	0.36	$23978	0.00%
GPFTGrapefruit USA, Inc.	$0.00	—	0.17	$71740	0.00%
GSACGelStat Corporation	$0.00	—	-4.57	$185394	0.00%
PEMTFThoughtful Brands Inc.	$0.00	—	0.00	$368	0.00%

About 4Front Ventures Corp.

4Front Ventures Corp. is an American company specializing in the management and operation of licensed cannabis facilities across various U.S. states where such activities are legally permitted. Its operations are bifurcated into two primary divisions: THC Cannabis and Cannabidiol (CBD) Wellness. The firm engages in the cultivation, manufacturing, distribution, and retail of both cannabis and CBD products. As of December 31, 2021, it oversaw six dispensaries, primarily under the MISSION brand, situated in Massachusetts, Illinois, and Michigan. In addition to its direct product offerings, 4Front Ventures extends its business to include the provision of equipment, supplies, and intellectual property to other cannabis producers, importing and reselling these materials, leasing real estate to cultivators, and furnishing consulting expertise. Founded in 2011, the company is headquartered in Phoenix, Arizona.

4Front Ventures Corp. (FFNTF) stock trades at $0.00 with a market capitalization of $1246. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.07, and currently trades 100.0% below its 52-week high.

On profitability, 4Front Ventures Corp. generates a return on equity (ROE) of 176.92% — well above the market average, a sign of a high-quality business, return on capital employed of -13.03%, an operating margin of -38.41%, a net profit margin of -48.15%.

Official website: 4frontventures.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides